Pharmaceuticals, Biotechnology and Life Sciences
Hansa Medical, a biopharmaceutical company focusing on novel immunomodulatory enzymes, has announced that the Committee for Orphan Medicinal Products (COMP)…
Galapagos has tested its filgotinib – JAK1 inhibitor – in a phase 2 study, for the patients with Chron’s disease, and…
NOXXON Pharma N.V. has announced a collaboration with Merck & Co. (MSD), Inc, under which the two companies will collaborate…
A cancer-focused drug-maker Bioven can now enrol patients in the USA in its international Phase III trial of EGF-PTI, in…
Kiadis Pharma N.V., a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders…
A biopharmaceutical company TiGenix focused on allogeneic expanded stem cells, has raised $35.65 million gross proceeds from the sale of 2,300,000 American Depository…
Argenx, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe…
Biocartis has CE-marked its solid biopsy Idylla NRAS-BRAF Mutation Test. On Thursday, Biocartis said that, together with the CE-marked Idylla…
Karuna Pharmaceuticals and a subsidiary of PureTech Health have finished studying antipsychotic for schizophrenia and Alzheimer’s disease – KarXT. The…
Horizon Discovery Group has provided an update on the commercial operation of its Biomanufacturing business with significant growth in cell…